BIO 2022 Notebook: Future Directions For R&D
News and views from day four of the BIO annual meeting include a fireside chat with FDA commissioner Robert Califf, gene therapy insights, and pharma efforts to provide cancer medicines in lower income countries.
You may also be interested in...
Global Cancer Coalition Seeks To Boost Access To Medicines In Lower-Income Countries
The Union for International Cancer Control and its industry and other partners say the Access to Oncology Medicines Coalition will help to facilitate access to cancer drugs in low- and lower-middle-income countries.
Sanofi Tries To ‘Bring More Of The Outside In’ For Diversity Efforts
The company is focusing first on gender parity as it navigates around tricky legal frameworks on collecting demographic data.